<?xml version="1.0" encoding="UTF-8"?><!--Transformation version 1.3--><legislativeDoc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.lexisnexis.com/xmlschemas/content/public/legislativedoc/1/" schemaVersion="1.0"><legislativeDocHead><citations><citeForThisResource citeDefinition="#7159#349#000038#     2#         3453#">Va. Code Ann. § 38.2-3453</citeForThisResource></citations><legislativeBodyInfo><jurisdiction><jurisSystem normalizedLongName="Virginia" normalizedShortName="VA"/></jurisdiction></legislativeBodyInfo></legislativeDocHead><legislativeDocBody><statute><level levelType="section"><anchor id="_38.2-3453"/><heading><desig>§ 38.2-3453.</desig><title>Clinical trials</title></heading><level levelType="paragraph"><anchor id="_a"/><heading><desig>A.</desig></heading><bodyText><p> Notwithstanding any provision of <citation type="statute" normalizedCite="VACODE 38.2-3418.8"><content><span normalizedCite="Va. Code Ann. § 38.2-3418.8">§ 38.2-3418.8<locator><locatorKey><keyName name="citeReference"/><keyValue value="#7159#349#000038#     2#       3418.8#"/></locatorKey></locator></span></content></citation> or any other section of this title to the contrary, if a health carrier offering a health benefit plan providing individual or group health insurance coverage provides coverage to a qualified individual, then such plan shall provide for participation in an approved clinical trial and cover routine patient costs for items and services furnished in connection with participation in such clinical trial. The health carrier shall not discriminate against the qualified individual on the basis of his participation in such clinical trial.</p></bodyText></level><level levelType="paragraph"><anchor id="_b"/><heading><desig>B.</desig></heading><bodyText><p> For purposes of this section:</p></bodyText><level levelType="paragraph"><anchor id="_b_1"/><heading><desig>1.</desig></heading><bodyText><p> "Approved clinical trial" means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or condition, and the study or investigation is (i) a federally funded or approved trial, (ii) conducted under an investigational new drug application reviewed by the U.S. Food and Drug Administration, or (iii) a drug trial that is exempt from having an investigational new drug application.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_2"/><heading><desig>2.</desig></heading><bodyText><p> "Life threatening condition" means any disease or condition from which the likelihood of death is probable unless the course of disease or condition is interrupted.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_3"/><heading><desig>3.</desig></heading><bodyText><p> "Qualified individual" means a covered person who is eligible to participate in an approved clinical trial according to the trial protocol, with respect to treatment of cancer or other life-threatening disease or condition, and the referring health care professional has concluded that the individual's participation in such trial is appropriate to treat the disease or condition, or the individual's participation is based on medical and scientific information.</p></bodyText></level><level levelType="paragraph"><anchor id="_b_4"/><heading><desig>4.</desig></heading><bodyText><p> "Routine patient costs" means all items and services consistent with the coverage provided under the health benefit plan that is typically covered for a qualified individual who is not enrolled in a clinical trial. Routine patient costs do not include the investigational item, device, or service itself; items or services that are provided solely to satisfy data collection and analysis needs and that are not used in the direct clinical management of the patient; or a service that is clearly inconsistent with widely accepted and established standards of care for a particular diagnosis.</p></bodyText></level></level><level levelType="paragraph"><anchor id="_c"/><heading><desig>C.</desig></heading><bodyText><p> Nothing in this section shall preclude a health benefit plan from requiring that a qualified individual participate in an approved clinical trial through a participating provider if such provider will accept the individual as a participant in the trial. However, a health benefit plan may not preclude a qualified individual from participating in an approved clinical trial conducted outside the state in which the individual resides.</p><p>This section shall not be construed to require that a health benefit plan provide benefits outside of the plan's health care provider network unless out-of-network benefits are otherwise provided under the plan.</p></bodyText></level><level levelType="paragraph"><anchor id="_d"/><heading><desig>D.</desig></heading><bodyText><p> This section shall not apply to any grandfathered plan providing individual or group health insurance coverage.</p></bodyText></level><history><historyGroup groupType="history-citation"><historyItem><bodyText><p><citation normalizedCite="2013 VA CH 751"><content><span normalizedCite="2013 Va. Ch. 751">2013, c. 751<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2013#000751#"/></locatorKey></locator></span></content></citation>.</p></bodyText></historyItem></historyGroup></history></level></statute></legislativeDocBody><metadata><dc:metadata xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:identifier identifierScheme="PGUID">urn:contentItem:5K0Y-PW80-004G-K1DN-00000-00</dc:identifier><dc:source sourceScheme="productContentSetIdentifier">10816</dc:source><dc:date dateType="last-updated">2016-06-15</dc:date></dc:metadata><publicationInfo><publicationName>CODE OF VIRGINIA </publicationName><copyright>Copyright © 2016  by Matthew Bender &amp; Company, Inc. a member of the LexisNexis Group. All rights reserved</copyright></publicationInfo><hierarchy><hierarchyLevel levelType="title"><heading><desig>TITLE 38.2.</desig><title>INSURANCE</title></heading><hierarchyLevel levelType="chapter"><heading><desig>CHAPTER 34.</desig><title>PROVISIONS RELATING TO ACCIDENT AND SICKNESS INSURANCE</title></heading><hierarchyLevel levelType="article"><heading><desig>ARTICLE 6.</desig><title>FEDERAL MARKET REFORMS.</title></heading></hierarchyLevel></hierarchyLevel></hierarchyLevel></hierarchy><classification classificationScheme="legal"><classificationItem><className>Healthcare Law</className><classCode>Z3VpZD11cm46dG9waWM6NkUxMkVDQjJDOEY5NDVDQ0E5NTFEMTlDMjIwNzVERjc7cGFyZW50Z3VpZD0</classCode><classificationItem><className>Experimental Treatment</className><classCode>Z3VpZD11cm46dG9waWM6QUNCMUU5MDQ3RUYwNDA0NkE3QzQ2MENFQzhBODYwNDQ7cGFyZW50Z3VpZD11cm46dG9waWM6NzYzODNGRDdGNkNDNDE4MTlDNTU4REQ1MEE3MUNFOEI</classCode></classificationItem></classificationItem></classification><classificationGroup classificationScheme="indexing-terms"><classification classificationScheme="legal"><classificationItem><className>Business &amp; Corporate Compliance</className><classCode>Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI7cGFyZW50Z3VpZD0</classCode><classificationItem score="90"><className>Insurance</className><classCode>Z3VpZD11cm46dG9waWM6MDM4MzQ2QUYzMTY0NDQzQTkxRDQwRUUzRUM5RDg0OEM7cGFyZW50Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI</classCode></classificationItem></classificationItem></classification></classificationGroup></metadata></legislativeDoc>